Drug manufacturers Moderna and Merck say a personalized mRNA cancer vaccine plus a drug called Keytruda reduced the return and spread of melanoma in high-risk patients. Dr. Jon LaPook and trial researcher Dr. Janice Mehnert have more information.
Drug manufacturers Moderna and Merck say a personalized mRNA cancer vaccine plus a drug called Keytruda reduced the return and spread of melanoma in high-risk patients. Dr. Jon LaPook and trial researcher Dr. Janice Mehnert have more information.
<iframe src="https://statesidedaily.com/embed/cluster/6d3247ddb59cb7d54684d172fd2a593fe7e973ad" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="This mRNA vaccine could potentially prevent the deadliest form of skin cancer"></iframe>
